By identifying PAF as a potential therapeutic target, this study opens a promising avenue for cancer treatment, suggesting that PAF inhibition, possibly in combination with other immunotherapies, could effectively dismantle the tumor‐favoring immune environment. This evidence concerns the gene PCLAF and neoplasm.